GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
31 hedge funds and large institutions have $9.25M invested in GreenLight Biosciences Holdings, PBC Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
19% more funds holding
Funds holding: 26 → 31 (+5)
0% less capital invested
Capital invested by funds: $9.28M → $9.25M (-$29.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
+$143K |
| 2 |
Rockefeller Capital Management
New York
|
+$79.6K |
| 3 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$39.9K |
| 4 |
AGM
Alpine Global Management
New York
|
+$37K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
+$27.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$618K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$168K |
| 3 |
CAC
Cowen and Company
New York
|
-$165K |
| 4 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$101K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$8.69K |
GRNAW Hedge Fund Activity: Q4 2021 in Review
31 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q4 2021, worth a combined $9.25M — down 0.31% from $9.28M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GRNAW positions and 3 closed out — a net gain of 5 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Kepos Capital, opening a new position worth an estimated $143K. The largest seller was Anson Funds Management, exiting entirely with an estimated $618K sold.
- 31 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q4 2021, up from 26 in Q3 2021.
- Funds reported $9.25M of GreenLight Biosciences Holdings, PBC Warrant stock for Q4 2021, down 0.31% quarter-over-quarter.
- 8 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q4 2021 and 3 closed out, a net change of +5 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q4 2021 was Kepos Capital, an estimated $143K added.
- The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q4 2021 was Anson Funds Management, an estimated $618K sold.
Based on aggregated 13F filings for Q4 2021.